Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.

Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Ghali WA, Knudtson ML; APPROACH Investigators..

J Am Coll Cardiol. 2004 Oct 19;44(8):1587-92.

2.

A review of heart failure management in the elderly population.

Cheng JW, Nayar M.

Am J Geriatr Pharmacother. 2009 Oct;7(5):233-49. doi: 10.1016/j.amjopharm.2009.10.001. Review.

PMID:
19948300
3.

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.

PMID:
16259523
4.

Practical algorithms for pharmacologic management of the post myocardial infarction patient.

Reiffel JA; American Heart Association.; American College of Cardiology..

Clin Cardiol. 2005 Nov;28(11 Suppl 1):I28-37. Review.

5.

Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors.

Mann JF, Gerstein HC, Pogue J, Lonn E, Yusuf S.

Am J Cardiovasc Drugs. 2002;2(3):157-62. Review.

PMID:
14727978
6.

Pharmacotherapy for systolic dysfunction: a review of randomized clinical trials.

Gheorghiade M, Benatar D, Konstam MA, Stoukides CA, Bonow RO.

Am J Cardiol. 1997 Oct 30;80(8B):14H-27H. Review. Erratum in: Am J Cardiol 1998 Jun 15;81(12):1521.

PMID:
9372994
7.

Prevention of heart failure.

Baker DW.

J Card Fail. 2002 Oct;8(5):333-46. Review.

PMID:
12411985
8.
9.

Pharmacotherapy for heart failure in patients with renal insufficiency.

Shlipak MG.

Ann Intern Med. 2003 Jun 3;138(11):917-24. Review.

PMID:
12779302
10.

Prevention and management of chronic heart failure in patients at risk.

Dei Cas L, Metra M, Nodari S, Dei Cas A, Gheorghiade M.

Am J Cardiol. 2003 May 8;91(9A):10F-17F. Review.

PMID:
12729847
11.

Prevention of heart failure.

Horwich TB, Fonarow GC.

Curr Cardiol Rep. 2002 May;4(3):194-9. Review.

PMID:
11960587
13.

Modern adjunctive pharmacotherapy of myocardial infarction.

Prasad A, Reeder G.

Expert Opin Pharmacother. 2000 Mar;1(3):405-18. Review.

PMID:
11249526
14.

Beta-blockers in left ventricular systolic dysfunction--from evidence to practice.

Bandyopadhyay S, O'Mahony MS.

Age Ageing. 2002 Jan;31(1):23-8. Review.

PMID:
11850304
15.

Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis.

Badve SV, Roberts MA, Hawley CM, Cass A, Garg AX, Krum H, Tonkin A, Perkovic V.

J Am Coll Cardiol. 2011 Sep 6;58(11):1152-61. doi: 10.1016/j.jacc.2011.04.041. Review.

16.

Combining aspirin with angiotensin converting enzyme inhibitors in heart failure: how safe is it?

Mehta H, Mahajan A, Bansal N, Vaidya S, Pathak L.

J Assoc Physicians India. 1998 Nov;46(11):953-6. Review.

PMID:
11229224
17.

Drug therapy of heart failure in the elderly.

Rich MW.

Am J Geriatr Cardiol. 2003 Jul-Aug;12(4):235-42. Review.

PMID:
12888704
18.

[Prognosis of heart failure--value of drug therapy].

Felix SB.

Z Kardiol. 1996;85 Suppl 4:1-7. Review. German.

PMID:
9027102
19.

Should beta-blockers form the cornerstone for the treatment of congestive heart failure?

Tabrizchi R.

Expert Rev Cardiovasc Ther. 2003 Jul;1(2):157-60. Review. No abstract available.

PMID:
15030275
20.

Pharmacology and pharmacotherapy of cardiovascular drugs in patients with chronic renal disease.

Barbour MM, McKindley DS.

Semin Nephrol. 2001 Jan;21(1):66-78. Review.

PMID:
11172561

Supplemental Content

Support Center